906 LEAD POISONING- COTTER
J.A.MA, July 3, 1954
Lawrence H. Cotter, M.D., New York
Chelating agents have been used
in industry for some time. The substance under consideration here, ethylene
diamine tetra-acetic acid, with the structural formula shown in the figure,
has proved valuable for recovering trace metals from foods and beverages
and rare metals in analyzing solutions. Pathologists find it useful in
decalcifying bone, and Gellhorn and others have used it clinically in
reducing hypercalcemia. The effects of the calcium chelate on the excretion
and storage of lead were studied by Rubin in his experiments on rabbits.
Many other animal studies have been reported, and it is in fairly general
use by veterinarians. Busman, Reid and Rubin reported a case in 1952 in
which lead encephalopathy in a human being was successfully treated by
intravenous injection of calcium disodium Versenate. The same year Belknap
obtained excellent results in three cases with the same treatment. Popovici
and associates found that the chelating agent was absorbed through the
skin in human beings with resultant diminution of the serum calcium. The
practicability of oral administration was, therefore, established, but
there remained the danger of eliminating the normal plasma electrolytes
coincidentally with lead. The recent development of a disodium calcium
salt of the amino acid (Versene) made treatment possible without this
disadvantage. It further proved to be pleasant to take, whereas all patients
had complained of the persistent nauseating taste of the acid. The method
employee in this series was to give a test dose of 25mg of Versene by
mouth. If no allergic symptoms were observed at the end of 24 hours, the
initial dose was repeated every 2 hours during the day until a total of
2gm had been given. This was continued for a week, by which time the patient
had received 14gm. There were no complaints, and most of the patients
volunteered the information that they felt an urge to urinate about 15
minutes after taking the pills.
HOOC-CH2
CH2-COOH
HOOC-CH2 CH2-COOH
From the Department of Medicine, Columbia University, College of Physicians
and surgeons, and Presbyterian Hospital.
Plumb, M, and Bersworth, FC: Displacement Series of Metal Complexes of
EDTA, J. Pys Colloid Chem. 54:1208, 1950.
Pharmacology, Physiology, Biochemistry and Toxicity of Versenes, Framingham,
MASS, Bersworth Chemical co, Sept 19, 1952
Birge, E.A. and Imhoff, C.E.: Versenate as Decalcifying Agent for Bone,
Am. J. Clin. Path. 22:192, 1952. Hahn, F.L., and Reygadas, F; Demineralization
of Hard Tissues, Science 114;462, 1951
Gellhorn, A: Personal communication to author.
Rubin, M: Gignac, S, and Popovici, A: Effect of Calcium Verseante on Storage
and Excretion of Lead in Rabbits, abstracted, J. Am. Chem.. Soc. 121:3J,
1952.
Holm, L.W.: Wheat, J.D.; Rhode, E.A.; and Firch, G: Treatment of Chronic
Lead Poisoning in Horses with Calcium disodium Ethylenediaminetetraacetate,
J. am. Bet. M.A. 123:38, 1953.
Bessman, S.P: Reid, H, and Rubin, M: Treatment of Lead Encephalopathy
with Calcium Disodium Versenate: Report of Case, M. Ann, District of Columbia
21:312, 1952.
Belknap, E.L: EDTA in Treatment of Lead Poisoning, Indust. Med. 21:305,
1952.
Popovici, A; Geschickter, C.F; Reinovsky, A and Rubin, M: Experimental
Control of Serum Calcium Levels in Vivo, Proc. Soc. Exper. Biol. &
Med. 74:415, 1950.



View all Webinars
You are about to visit a third-party site. We are not responsible for the information contained on third-party sites. Do you wish to continue?